Variant report

Variant	rs16823660
Chromosome Location	chr2:183623760-183623761
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:183622731..183624252-chr2:183625888..183627970,2	K562	blood:
2	chr2:183615250..183618246-chr2:183622533..183624342,2	K562	blood:

Extended variants
information (count: 24 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:16)

rs_ID	r²[population]
rs10196982	0.96[AFR][1000 genomes];1.00[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs10211132	0.87[AFR][1000 genomes]
rs13414223	1.00[CHB][hapmap];1.00[JPT][hapmap];0.85[YRI][hapmap];0.83[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs1881097	1.00[ASW][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];1.00[GIH][hapmap];1.00[JPT][hapmap];1.00[LWK][hapmap];1.00[MEX][hapmap];1.00[MKK][hapmap];1.00[TSI][hapmap];1.00[YRI][hapmap];0.91[AFR][1000 genomes];1.00[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs1881098	1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.91[AFR][1000 genomes];1.00[AMR][1000 genomes];0.93[ASN][1000 genomes]
rs288266	1.00[JPT][hapmap];1.00[MEX][hapmap];1.00[TSI][hapmap]
rs288277	0.85[ASN][1000 genomes]
rs288279	0.91[CHB][hapmap];1.00[JPT][hapmap];0.85[ASN][1000 genomes]
rs288284	0.91[ASN][1000 genomes]
rs288286	0.91[ASN][1000 genomes]
rs288297	0.91[ASN][1000 genomes]
rs288298	0.91[ASN][1000 genomes]
rs288333	0.91[ASN][1000 genomes]
rs288345	0.91[ASN][1000 genomes]
rs288352	0.87[ASN][1000 genomes]
rs9288085	0.96[AFR][1000 genomes];0.87[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1009882	chr2:183213152-184171519	Weak transcription Strong transcription Flanking Active TSS Enhancers Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
2	esv2757842	chr2:183437700-183835084	Strong transcription Flanking Active TSS Weak transcription Enhancers ZNF genes & repeats Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases
3	esv2759104	chr2:183437700-183835084	Weak transcription Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS ZNF genes & repeats Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases
4	esv2756954	chr2:183528670-183764930	Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Strong transcription Bivalent/Poised TSS Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
5	nsv875483	chr2:183537399-183657867	Weak transcription Enhancers Strong transcription Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	15 gene(s)	inside rSNPs	diseases
6	esv34847	chr2:183537399-183786763	Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
7	esv3693445	chr2:183542825-183725221	Weak transcription Strong transcription Enhancers Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	16 gene(s)	inside rSNPs	diseases
8	nsv10204	chr2:183609768-183639750	Weak transcription Strong transcription ZNF genes & repeats Enhancers Genic enhancers Active TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:125 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:183581800-183631000	Weak transcription	Esophagus	oesophagus
2	chr2:183581800-183647600	Weak transcription	Gastric	stomach
3	chr2:183581800-183655600	Weak transcription	Pancreas	Pancrea
4	chr2:183582600-183624400	Weak transcription	Stomach Mucosa	stomach
5	chr2:183588600-183624200	Weak transcription	Small Intestine	intestine
6	chr2:183602600-183624200	Weak transcription	Primary T killer memory cells from peripheral blood	blood
7	chr2:183605600-183646000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
8	chr2:183606000-183624200	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
9	chr2:183607200-183638800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr2:183608000-183624200	Weak transcription	Fetal Stomach	stomach
11	chr2:183608000-183628200	Weak transcription	Fetal Intestine Small	intestine
12	chr2:183609000-183646600	Weak transcription	Hela-S3	cervix
13	chr2:183610000-183638800	Weak transcription	Lung	lung
14	chr2:183610200-183623800	Weak transcription	Psoas Muscle	Psoas
15	chr2:183610200-183624400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
16	chr2:183610200-183624400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
17	chr2:183610200-183624400	Weak transcription	Aorta	Aorta
18	chr2:183610200-183626000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
19	chr2:183610200-183626600	Weak transcription	Brain Hippocampus Middle	brain
20	chr2:183610200-183628400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
21	chr2:183610200-183631400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
22	chr2:183610200-183633200	Weak transcription	Spleen	Spleen
23	chr2:183610200-183639000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
24	chr2:183613200-183625000	Strong transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr2:183613400-183624200	Weak transcription	Pancreatic Islets	Pancreatic Islet
26	chr2:183614400-183626400	Strong transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
27	chr2:183614400-183626400	Strong transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr2:183614400-183626600	Strong transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
29	chr2:183614400-183631200	Strong transcription	HUES64 Cell Line	embryonic stem cell
30	chr2:183614400-183632200	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
31	chr2:183614400-183632400	Strong transcription	Primary Natural Killer cells fromperipheralblood	blood
32	chr2:183614400-183633200	Strong transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
33	chr2:183614400-183633400	Strong transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
34	chr2:183614400-183633400	Strong transcription	Primary monocytes fromperipheralblood	blood
35	chr2:183614400-183633800	Strong transcription	Monocytes-CD14+_RO01746	blood
36	chr2:183614400-183634200	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
37	chr2:183614600-183625000	Strong transcription	Liver	Liver
38	chr2:183614600-183626400	Strong transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr2:183614600-183627000	Strong transcription	ES-UCSF4 Cell Line	embryonic stem cell
40	chr2:183614600-183630000	Strong transcription	iPS-18 Cell Line	embryonic stem cell
41	chr2:183614600-183633200	Strong transcription	Primary B cells from peripheral blood	blood
42	chr2:183614600-183633600	Strong transcription	Fetal Intestine Large	intestine
43	chr2:183614600-183633600	Strong transcription	Dnd41	blood
44	chr2:183614600-183633800	Strong transcription	HUES48 Cell Line	embryonic stem cell
45	chr2:183614600-183634000	Strong transcription	HUES6 Cell Line	embryonic stem cell
46	chr2:183614600-183634000	Strong transcription	iPS-20b Cell Line	embryonic stem cell
47	chr2:183614800-183632200	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
48	chr2:183615000-183627000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
49	chr2:183615200-183633400	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
50	chr2:183615200-183633600	Strong transcription	Primary T helper cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links